Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000647832 | SCV000769635 | likely benign | Neuropathy, hereditary sensory and autonomic, type 2A; Pseudohypoaldosteronism type 2C | 2024-10-03 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV002261155 | SCV002541181 | uncertain significance | not provided | 2021-10-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002360614 | SCV002660740 | uncertain significance | Inborn genetic diseases | 2023-09-15 | criteria provided, single submitter | clinical testing | The c.6476C>T (p.P2159L) alteration is located in exon 24 (coding exon 24) of the WNK1 gene. This alteration results from a C to T substitution at nucleotide position 6476, causing the proline (P) at amino acid position 2159 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV000647832 | SCV005631503 | uncertain significance | Neuropathy, hereditary sensory and autonomic, type 2A; Pseudohypoaldosteronism type 2C | 2024-04-11 | criteria provided, single submitter | clinical testing |